Industry: Service & Software
Published Date: 2026-03-12
Pages: 93 Pages
Report ld: 6222513
Request Sample
Customized Report
Pharmaceutical Decommissioning Service Market Size(US$)

CAGR 2026-2032
5.6%
Market Size,2032
USD 1,170
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Decommissioning Service market size was US$ 803 million in 2025 and is forecast to reach a readjusted size of US$ 1170 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Pharmaceutical Decommissioning Service is a one-stop professional service from assessment, planning, demolition, disposal to site restoration and reuse for production facilities, equipment, plants and related systems that are decommissioned by pharmaceutical companies due to equipment aging, technology upgrades, regulatory requirements or corporate strategy adjustments. It covers equipment compliance inspection, hazardous substance treatment, waste environmental recycling, safe demolition of building structures and site ecological restoration, ensuring that the decommissioning process complies with the Good Manufacturing Practice (GMP) for pharmaceuticals, environmental protection regulations and safety production standards. At the same time, through resource recycling and site function reconstruction, it helps companies achieve sustainable development goals.
In 2025, the North America Pharmaceutical Decommissioning Service market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
The global key players of Pharmaceutical Decommissioning Service include KDC Veolia, RCS Pharma, Technical Safety Services, ISPE, Brilliant Equipment Services, Qualitech Environmental Services, Hughes & Salvidge, Divestiture, Pharmagraph, RVA Group, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of revenue, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Pharmaceutical Decommissioning Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pharmaceutical Decommissioning Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Equipment Decommissioning Service
1.2.3 Facility Decommissioning Service
1.2.4 Laboratory Decommissioning Service
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Manufacturers
1.3.3 Pharmaceutical CDMO
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Decommissioning Service Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Pharmaceutical Decommissioning Service Market Share by Revenue, by Region (2021-2026)
2.4 Global Pharmaceutical Decommissioning Service Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Pharmaceutical Decommissioning Service Market Size and Prospective (2021-2032)
2.5.2 Europe Pharmaceutical Decommissioning Service Market Size and Prospective (2021-2032)
2.5.3 China Pharmaceutical Decommissioning Service Market Size and Prospective (2021-2032)
2.5.4 Japan Pharmaceutical Decommissioning Service Market Size and Prospective (2021-2032)
2.5.5 Southeast Asia Pharmaceutical Decommissioning Service Market Size and Prospective (2021-2032)
2.5.6 India Pharmaceutical Decommissioning Service Market Size and Prospective (2021-2032)
2.5.7 South America Pharmaceutical Decommissioning Service Market Size and Prospective (2021-2032)
2.5.8 Middle East Pharmaceutical Decommissioning Service Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Pharmaceutical Decommissioning Service Historical Market Size by Type (2021-2026)
3.2 Global Pharmaceutical Decommissioning Service Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Pharmaceutical Decommissioning Service
4 Breakdown Data by Application
4.1 Global Pharmaceutical Decommissioning Service Historical Market Size by Application (2021-2026)
4.2 Global Pharmaceutical Decommissioning Service Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Pharmaceutical Decommissioning Service Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Pharmaceutical Decommissioning Service Players by Revenue (2021-2026)
5.1.2 Global Pharmaceutical Decommissioning Service Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Pharmaceutical Decommissioning Service Revenue
5.4 Global Pharmaceutical Decommissioning Service Market Concentration Analysis
5.4.1 Global Pharmaceutical Decommissioning Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Decommissioning Service Revenue in 2025
5.5 Global Key Players of Pharmaceutical Decommissioning Service Head Offices and Areas Served
5.6 Global Key Players of Pharmaceutical Decommissioning Service, Product and Application
5.7 Global Key Players of Pharmaceutical Decommissioning Service, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Pharmaceutical Decommissioning Service Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Pharmaceutical Decommissioning Service Market Size by Type (2021-2026)
6.1.2.2 North America Pharmaceutical Decommissioning Service Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Pharmaceutical Decommissioning Service Market Size by Application (2021-2026)
6.1.3.2 North America Pharmaceutical Decommissioning Service Market Share by Application (2021-2026)
6.1.4 North America Pharmaceutical Decommissioning Service Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Pharmaceutical Decommissioning Service Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Pharmaceutical Decommissioning Service Market Size by Type (2021-2026)
6.2.2.2 Europe Pharmaceutical Decommissioning Service Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Pharmaceutical Decommissioning Service Market Size by Application (2021-2026)
6.2.3.2 Europe Pharmaceutical Decommissioning Service Market Share by Application (2021-2026)
6.2.4 Europe Pharmaceutical Decommissioning Service Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Pharmaceutical Decommissioning Service Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Pharmaceutical Decommissioning Service Market Size by Type (2021-2026)
6.3.2.2 China Pharmaceutical Decommissioning Service Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Pharmaceutical Decommissioning Service Market Size by Application (2021-2026)
6.3.3.2 China Pharmaceutical Decommissioning Service Market Share by Application (2021-2026)
6.3.4 China Pharmaceutical Decommissioning Service Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Pharmaceutical Decommissioning Service Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Pharmaceutical Decommissioning Service Market Size by Type (2021-2026)
6.4.2.2 Japan Pharmaceutical Decommissioning Service Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Pharmaceutical Decommissioning Service Market Size by Application (2021-2026)
6.4.3.2 Japan Pharmaceutical Decommissioning Service Market Share by Application (2021-2026)
6.4.4 Japan Pharmaceutical Decommissioning Service Major Customers
6.4.5 Japan Market Trends and Opportunities
6.5 Southeast Asia Market: Players, Segments, Downstream and Major Customers
6.5.1 Southeast Asia Pharmaceutical Decommissioning Service Revenue by Company (2021-2026)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Pharmaceutical Decommissioning Service Market Size by Type (2021-2026)
6.5.2.2 Southeast Asia Pharmaceutical Decommissioning Service Market Share by Type (2021-2026)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Pharmaceutical Decommissioning Service Market Size by Application (2021-2026)
6.5.3.2 Southeast Asia Pharmaceutical Decommissioning Service Market Share by Application (2021-2026)
6.5.4 Southeast Asia Pharmaceutical Decommissioning Service Major Customers
6.5.5 Southeast Asia Market Trends and Opportunities
6.6 India Market: Players, Segments, Downstream and Major Customers
6.6.1 India Pharmaceutical Decommissioning Service Revenue by Company (2021-2026)
6.6.2 India Market Size by Type
6.6.2.1 India Pharmaceutical Decommissioning Service Market Size by Type (2021-2026)
6.6.2.2 India Pharmaceutical Decommissioning Service Market Share by Type (2021-2026)
6.6.3 India Market Size by Application
6.6.3.1 India Pharmaceutical Decommissioning Service Market Size by Application (2021-2026)
6.6.3.2 India Pharmaceutical Decommissioning Service Market Share by Application (2021-2026)
6.6.4 India Pharmaceutical Decommissioning Service Major Customers
6.6.5 India Market Trends and Opportunities
7 Key Player Profiles
7.1 KDC Veolia
7.1.1 KDC Veolia Company Details
7.1.2 KDC Veolia Business Overview
7.1.3 KDC Veolia Pharmaceutical Decommissioning Service Introduction
7.1.4 KDC Veolia Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.1.5 KDC Veolia Recent Development
7.2 RCS Pharma
7.2.1 RCS Pharma Company Details
7.2.2 RCS Pharma Business Overview
7.2.3 RCS Pharma Pharmaceutical Decommissioning Service Introduction
7.2.4 RCS Pharma Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.2.5 RCS Pharma Recent Development
7.3 Technical Safety Services
7.3.1 Technical Safety Services Company Details
7.3.2 Technical Safety Services Business Overview
7.3.3 Technical Safety Services Pharmaceutical Decommissioning Service Introduction
7.3.4 Technical Safety Services Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.3.5 Technical Safety Services Recent Development
7.4 ISPE
7.4.1 ISPE Company Details
7.4.2 ISPE Business Overview
7.4.3 ISPE Pharmaceutical Decommissioning Service Introduction
7.4.4 ISPE Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.4.5 ISPE Recent Development
7.5 Brilliant Equipment Services
7.5.1 Brilliant Equipment Services Company Details
7.5.2 Brilliant Equipment Services Business Overview
7.5.3 Brilliant Equipment Services Pharmaceutical Decommissioning Service Introduction
7.5.4 Brilliant Equipment Services Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.5.5 Brilliant Equipment Services Recent Development
7.6 Qualitech Environmental Services
7.6.1 Qualitech Environmental Services Company Details
7.6.2 Qualitech Environmental Services Business Overview
7.6.3 Qualitech Environmental Services Pharmaceutical Decommissioning Service Introduction
7.6.4 Qualitech Environmental Services Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.6.5 Qualitech Environmental Services Recent Development
7.7 Hughes & Salvidge
7.7.1 Hughes & Salvidge Company Details
7.7.2 Hughes & Salvidge Business Overview
7.7.3 Hughes & Salvidge Pharmaceutical Decommissioning Service Introduction
7.7.4 Hughes & Salvidge Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.7.5 Hughes & Salvidge Recent Development
7.8 Divestiture
7.8.1 Divestiture Company Details
7.8.2 Divestiture Business Overview
7.8.3 Divestiture Pharmaceutical Decommissioning Service Introduction
7.8.4 Divestiture Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.8.5 Divestiture Recent Development
7.9 Pharmagraph
7.9.1 Pharmagraph Company Details
7.9.2 Pharmagraph Business Overview
7.9.3 Pharmagraph Pharmaceutical Decommissioning Service Introduction
7.9.4 Pharmagraph Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.9.5 Pharmagraph Recent Development
7.10 RVA Group
7.10.1 RVA Group Company Details
7.10.2 RVA Group Business Overview
7.10.3 RVA Group Pharmaceutical Decommissioning Service Introduction
7.10.4 RVA Group Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.10.5 RVA Group Recent Development
7.11 DSM Demolition
7.11.1 DSM Demolition Company Details
7.11.2 DSM Demolition Business Overview
7.11.3 DSM Demolition Pharmaceutical Decommissioning Service Introduction
7.11.4 DSM Demolition Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.11.5 DSM Demolition Recent Development
7.12 KERAMIDA Inc
7.12.1 KERAMIDA Inc Company Details
7.12.2 KERAMIDA Inc Business Overview
7.12.3 KERAMIDA Inc Pharmaceutical Decommissioning Service Introduction
7.12.4 KERAMIDA Inc Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.12.5 KERAMIDA Inc Recent Development
7.13 Downwell Enabling Solutions
7.13.1 Downwell Enabling Solutions Company Details
7.13.2 Downwell Enabling Solutions Business Overview
7.13.3 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Introduction
7.13.4 Downwell Enabling Solutions Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
7.13.5 Downwell Enabling Solutions Recent Development
8 Pharmaceutical Decommissioning Service Market Dynamics
8.1 Pharmaceutical Decommissioning Service Industry Trends
8.2 Pharmaceutical Decommissioning Service Market Drivers
8.3 Pharmaceutical Decommissioning Service Market Challenges
8.4 Pharmaceutical Decommissioning Service Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1170 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-12
Pages: 143
USD 4900.00
(Single User License)
The global Pharmaceutical Decommissioning Service market was valued at US$ 803 million in 2025 and is anticipated to reach US$ 1170 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 114
USD 2900.00
(Single User License)
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 803 million in 2025 and is projected to reach US$ 1170 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 106
USD 3950.00
(Single User License)
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-06-18
Pages: 119
USD 3950.00
(Single User License)
The global Pharmaceutical Decommissioning Service market size was US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published Date: 2025-06-18
Pages: 93
USD 4250.00
(Single User License)
The global market for Pharmaceutical Decommissioning Service was valued at US$ 785 million in the year 2024 and is projected to reach a revised size of US$ 1114 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published Date: 2025-06-18
Pages: 84
USD 2900.00
(Single User License)
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1114 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Published Date: 2025-06-18
Pages: 145
USD 4900.00
(Single User License)
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1170 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-12
Pages: 143
The global Pharmaceutical Decommissioning Service market was valued at US$ 803 million in 2025 and is anticipated to reach US$ 1170 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 114
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 803 million in 2025 and is projected to reach US$ 1170 million, growing at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 106
The global market for Pharmaceutical Decommissioning Service was estimated to be worth US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-06-18
Pages: 119
The global Pharmaceutical Decommissioning Service market size was US$ 785 million in 2024 and is forecast to a readjusted size of US$ 1114 million by 2031 with a CAGR of 5.6% during the forecast period 2025-2031.
Published: 2025-06-18
Pages: 93
The global market for Pharmaceutical Decommissioning Service was valued at US$ 785 million in the year 2024 and is projected to reach a revised size of US$ 1114 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Published: 2025-06-18
Pages: 84
The global Pharmaceutical Decommissioning Service market is projected to grow from US$ 803 million in 2025 to US$ 1114 million by 2031, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Published: 2025-06-18
Pages: 145
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now